首页 > 最新文献

Pathophysiology最新文献

英文 中文
Correction: Yamarthi et al. Sepia pharaonis Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. Pathophysiology 2024, 31, 408-419.
IF 2.7 Q2 PATHOLOGY Pub Date : 2025-01-20 DOI: 10.3390/pathophysiology32010004
Prathyusha Yamarthi, Rama Satyasri Kotipalli, Samatasai Patnaik, Kv Veena, Muralidharan Kathirvel, Rajkumar Vutukuri, Manjula Bhanoori

Error in Figure [...].

{"title":"Correction: Yamarthi et al. <i>Sepia pharaonis</i> Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. <i>Pathophysiology</i> 2024, <i>31</i>, 408-419.","authors":"Prathyusha Yamarthi, Rama Satyasri Kotipalli, Samatasai Patnaik, Kv Veena, Muralidharan Kathirvel, Rajkumar Vutukuri, Manjula Bhanoori","doi":"10.3390/pathophysiology32010004","DOIUrl":"10.3390/pathophysiology32010004","url":null,"abstract":"<p><p><b>Error in Figure</b> [...].</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"32 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome.
IF 2.7 Q2 PATHOLOGY Pub Date : 2025-01-10 DOI: 10.3390/pathophysiology32010003
Vedashree R Meher, Richard J Huntsman, Francis H Y Green, Jill C Wooff, Roland N Auer

Background: Cause of death analysis is fundamental to forensic pathology. We present the case of a 9½-year-old girl with a genetically confirmed diagnosis of Dravet syndrome who died in her sleep with no evidence of motor seizure. She also had a lifelong history of recurrent pneumonias and, along with her family, had tested positive for COVID-19 10 days before death. Methods: Long-term clinical history of Dravet Syndrome and respiratory infections were obtained from patient's medical charts and radiology reports. A Rapid-Antigen Test was used to confirm SARS-CoV2 infection days prior to death. At autopsy, brain, heart and lung tissues were obtained. Paraffin-embedded tissues were double-stained with H&E, and immunohistochemically stained using various antibodies. Results: Autopsy revealed evidence of previous seizure activity in the brain and cellular interstitial thickening in the lung. The brain showed edema and fibrillary gliosis without neuronal loss in neocortex and hippocampus. The lung showed inflammatory interstitial thickening with histiocytes, megakaryocytes, B-lymphocytes, and T-lymphocytes, including helper/suppressor cells and cytotoxic T-lymphocytes. Diffuse alveolar damage was observed as alveolar flooding with proteinaceous fluid. Conclusions: The cause of death may be attributed to Sudden Unexpected Death in Epilepsy (SUDEP) in Dravet syndrome, sudden death in viral pneumonia, or some combination of the two. When two independent risk factors for sudden unexpected death are identified due to co-pathology, it may not be possible to determine a single cause of death beyond a reasonable doubt.

{"title":"Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome.","authors":"Vedashree R Meher, Richard J Huntsman, Francis H Y Green, Jill C Wooff, Roland N Auer","doi":"10.3390/pathophysiology32010003","DOIUrl":"10.3390/pathophysiology32010003","url":null,"abstract":"<p><p><b>Background</b>: Cause of death analysis is fundamental to forensic pathology. We present the case of a 9½-year-old girl with a genetically confirmed diagnosis of Dravet syndrome who died in her sleep with no evidence of motor seizure. She also had a lifelong history of recurrent pneumonias and, along with her family, had tested positive for COVID-19 10 days before death. <b>Methods</b>: Long-term clinical history of Dravet Syndrome and respiratory infections were obtained from patient's medical charts and radiology reports. A Rapid-Antigen Test was used to confirm SARS-CoV2 infection days prior to death. At autopsy, brain, heart and lung tissues were obtained. Paraffin-embedded tissues were double-stained with H&E, and immunohistochemically stained using various antibodies. <b>Results</b>: Autopsy revealed evidence of previous seizure activity in the brain and cellular interstitial thickening in the lung. The brain showed edema and fibrillary gliosis without neuronal loss in neocortex and hippocampus. The lung showed inflammatory interstitial thickening with histiocytes, megakaryocytes, B-lymphocytes, and T-lymphocytes, including helper/suppressor cells and cytotoxic T-lymphocytes. Diffuse alveolar damage was observed as alveolar flooding with proteinaceous fluid. <b>Conclusions</b>: The cause of death may be attributed to Sudden Unexpected Death in Epilepsy (SUDEP) in Dravet syndrome, sudden death in viral pneumonia, or some combination of the two. When two independent risk factors for sudden unexpected death are identified due to co-pathology, it may not be possible to determine a single cause of death beyond a reasonable doubt.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"32 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study.
IF 2.7 Q2 PATHOLOGY Pub Date : 2025-01-06 DOI: 10.3390/pathophysiology32010002
Victor Augusto Ramos Fernandes, Gabriela Pereira Dos Santos, Amilton Iatecola, Daniela Vieira Buchaim, Ionaly Judith Faria Garcia, Carlos Henrique Bertoni Reis, Lívia Maluf Menegazzo Bueno, Bruna Trazzi Pagani, Rogerio Leone Buchaim, Marcelo Rodrigues da Cunha

Background/Objectives: Duchenne muscular dystrophy (DMD) is a genetic disease characterized by a lack of dystrophin caused by mutations in the DMD gene, and some minor cases are due to decreased levels of dystrophin, leading to muscle weakness and motor impairment. Creatine supplementation has demonstrated several benefits for the muscle, such as increased strength, enhanced tissue repair, and improved ATP resynthesis. This preliminary study aimed to investigate the effects of creatine on the gastrocnemius muscle in dystrophy muscle (MDX) and healthy C57BL/10 mice. Methods: Twenty MDX and C57Bl/10 mice were organized into groups and supplemented or not with creatine in a dosage of 0.3 mg for 8 weeks. Gastrocnemius tissue was analyzed using histomorphology and histomorphometric techniques. Results: The results demonstrated potential anti-inflammatory effects of creatine, with less observation of inflammatory infiltrates, the preservation of intramuscular glycogen, and reduction in tissue fibrosis in supplemented animals. Conclusions: These findings suggest that creatine may enhance tissue function and slow the progression of DMD. However, further research, with more analysis, is needed to elucidate molecular mechanisms underlying creatine's effects on reducing mononuclear leukocytes and its role in mitigating tissue fibrosis.

{"title":"Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study.","authors":"Victor Augusto Ramos Fernandes, Gabriela Pereira Dos Santos, Amilton Iatecola, Daniela Vieira Buchaim, Ionaly Judith Faria Garcia, Carlos Henrique Bertoni Reis, Lívia Maluf Menegazzo Bueno, Bruna Trazzi Pagani, Rogerio Leone Buchaim, Marcelo Rodrigues da Cunha","doi":"10.3390/pathophysiology32010002","DOIUrl":"10.3390/pathophysiology32010002","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Duchenne muscular dystrophy (DMD) is a genetic disease characterized by a lack of dystrophin caused by mutations in the DMD gene, and some minor cases are due to decreased levels of dystrophin, leading to muscle weakness and motor impairment. Creatine supplementation has demonstrated several benefits for the muscle, such as increased strength, enhanced tissue repair, and improved ATP resynthesis. This preliminary study aimed to investigate the effects of creatine on the gastrocnemius muscle in dystrophy muscle (MDX) and healthy C57BL/10 mice. <b>Methods:</b> Twenty MDX and C57Bl/10 mice were organized into groups and supplemented or not with creatine in a dosage of 0.3 mg for 8 weeks. Gastrocnemius tissue was analyzed using histomorphology and histomorphometric techniques. <b>Results:</b> The results demonstrated potential anti-inflammatory effects of creatine, with less observation of inflammatory infiltrates, the preservation of intramuscular glycogen, and reduction in tissue fibrosis in supplemented animals. <b>Conclusions:</b> These findings suggest that creatine may enhance tissue function and slow the progression of DMD. However, further research, with more analysis, is needed to elucidate molecular mechanisms underlying creatine's effects on reducing mononuclear leukocytes and its role in mitigating tissue fibrosis.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"32 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD.
IF 2.7 Q2 PATHOLOGY Pub Date : 2025-01-03 DOI: 10.3390/pathophysiology32010001
Ester S Alves, Jessica D M Santos, Alessandra G Cruz, Felipe N Camargo, Carlos H Z Talarico, Anne R M Santos, Carlos A A Silva, Henrique J N Morgan, Sandro L Matos, Layanne C C Araujo, João Paulo Camporez

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with cardiometabolic risk. Although studies have shown that estradiol positively contributes to energy metabolism via estrogen receptor alpha (ERα), its role specifically in the liver is not defined. Therefore, this study aimed to evaluate the effects of ERα overexpression, specifically in the liver in mice fed a high-fat diet (HFD). Methods: Male C57BL/6J mice were divided into four groups, vehicle fed with regular chow (RC) (RC-Vehicle); vehicle fed an HFD (HFD-Vehicle); AAV-treated fed with RC (RC-AAV); and AAV-treated fed an HFD (HFD-AAV), for 6 weeks (8-10 mice per group). AAV was administered intravenously to induce ERα overexpression. Results: We demonstrate that overexpression of ERα in RC-fed mice reduces body fat (28%). These mice show increased oxygen consumption in cultured primary hepatocytes, both in basal (19%) and maximal respiration (34%). In HFD-fed mice, we showed a decrease in hepatic TAG content (43%) associated with improved hepatic insulin sensitivity (145%). Conclusions: From this perspective, our results prove that hepatic ERα signaling is responsible for some of the metabolic protective effects of estrogen in mice. Overexpression of ERα improves hepatocyte mitochondrial function, consequently reducing hepatic lipid accumulation and protecting animals from hepatic steatosis and hepatic insulin resistance. Further investigations will be needed to determine the exact molecular mechanism by which ERα improves hepatic metabolic health.

{"title":"Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD.","authors":"Ester S Alves, Jessica D M Santos, Alessandra G Cruz, Felipe N Camargo, Carlos H Z Talarico, Anne R M Santos, Carlos A A Silva, Henrique J N Morgan, Sandro L Matos, Layanne C C Araujo, João Paulo Camporez","doi":"10.3390/pathophysiology32010001","DOIUrl":"10.3390/pathophysiology32010001","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with cardiometabolic risk. Although studies have shown that estradiol positively contributes to energy metabolism via estrogen receptor alpha (ERα), its role specifically in the liver is not defined. Therefore, this study aimed to evaluate the effects of ERα overexpression, specifically in the liver in mice fed a high-fat diet (HFD). <b>Methods:</b> Male C57BL/6J mice were divided into four groups, vehicle fed with regular chow (RC) (RC-Vehicle); vehicle fed an HFD (HFD-Vehicle); AAV-treated fed with RC (RC-AAV); and AAV-treated fed an HFD (HFD-AAV), for 6 weeks (8-10 mice per group). AAV was administered intravenously to induce ERα overexpression. <b>Results:</b> We demonstrate that overexpression of ERα in RC-fed mice reduces body fat (28%). These mice show increased oxygen consumption in cultured primary hepatocytes, both in basal (19%) and maximal respiration (34%). In HFD-fed mice, we showed a decrease in hepatic TAG content (43%) associated with improved hepatic insulin sensitivity (145%). <b>Conclusions:</b> From this perspective, our results prove that hepatic ERα signaling is responsible for some of the metabolic protective effects of estrogen in mice. Overexpression of ERα improves hepatocyte mitochondrial function, consequently reducing hepatic lipid accumulation and protecting animals from hepatic steatosis and hepatic insulin resistance. Further investigations will be needed to determine the exact molecular mechanism by which ERα improves hepatic metabolic health.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"32 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors. 新诊断CML的低Renalase水平:对酪氨酸激酶抑制剂调节敏感的失调。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-12-10 DOI: 10.3390/pathophysiology31040053
Jelena Milenkovic, Dijana Stojanovic, Sanja Velickovic, Branka Djordjevic, Goran Marjanovic, Maja Milojkovic

Background: A dysregulated proinflammatory microenvironment is considered one of the reasons why current therapies of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKI) do not secure disease control. Therefore, the development of BCR-ABL1-independent therapies is encouraged. Renalase (RNLS) is a multifunctional protein that exhibits both enzymatic and non-enzymatic cytokine-like properties, along with potent anti-inflammatory and anti-apoptotic effects. It is expressed in various tissues, including tumors. Methods: We investigated the levels of RNLS in the blood of CML patients in the chronic phase, treatment naïve patients, and those in remission under TKI treatment (either imatinib or nilotinib) and compared them to healthy individuals. Results: Renalase concentration was markedly decreased in treatment-naive CML patients compared to other groups (p = 0.000), while lower levels in the TKI group were not statistically significant compared to controls. The levels correlated negatively with the total leukocyte and neutrophil count (p < 0.05), while a positive correlation was present with CRP levels in treatment naïve patients. Conclusions: Dynamic regulation of RNLS expression and activity is coupled with transcription factors NF-κB and STAT3. Interpretation of our results might rely on differential requirements of activated STATs (STAT3/5) during CML clone development and maintenance, including the observation of RNLS rise upon TKI introduction. Overall, our research provides new insights into the field of hematological malignancies. Unlike other malignancies studied, RNLS plasma levels are significantly decreased in CML. In future perspectives, RNLS could potentially serve as a diagnostic, prognostic, or therapeutic option for these patients.

背景:促炎微环境失调被认为是目前使用酪氨酸激酶抑制剂(TKI)治疗慢性髓性白血病(CML)不能确保疾病控制的原因之一。因此,bcr - abl1独立疗法的发展受到鼓励。Renalase (RNLS)是一种多功能蛋白,具有酶促和非酶促细胞因子样特性,以及有效的抗炎和抗凋亡作用。它在包括肿瘤在内的各种组织中表达。方法:我们研究了慢性粒细胞白血病(CML)患者、治疗naïve患者和TKI治疗(伊马替尼或尼罗替尼)缓解期患者血液中RNLS的水平,并将其与健康个体进行比较。结果:初治CML患者Renalase浓度较其他组明显降低(p = 0.000),而TKI组Renalase浓度较对照组降低无统计学意义。CRP水平与总白细胞、中性粒细胞计数呈负相关(p < 0.05),与naïve组CRP水平呈正相关。结论:RNLS表达和活性的动态调控与转录因子NF-κB和STAT3相关。对我们的结果的解释可能依赖于CML克隆开发和维持过程中活化STATs (STAT3/5)的不同需求,包括观察到TKI引入后RNLS的上升。总的来说,我们的研究为血液系统恶性肿瘤领域提供了新的见解。与研究的其他恶性肿瘤不同,CML患者的RNLS血浆水平显著降低。从未来的角度来看,RNLS可能会成为这些患者的诊断、预后或治疗选择。
{"title":"Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors.","authors":"Jelena Milenkovic, Dijana Stojanovic, Sanja Velickovic, Branka Djordjevic, Goran Marjanovic, Maja Milojkovic","doi":"10.3390/pathophysiology31040053","DOIUrl":"10.3390/pathophysiology31040053","url":null,"abstract":"<p><p><b>Background:</b> A dysregulated proinflammatory microenvironment is considered one of the reasons why current therapies of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKI) do not secure disease control. Therefore, the development of BCR-ABL1-independent therapies is encouraged. Renalase (RNLS) is a multifunctional protein that exhibits both enzymatic and non-enzymatic cytokine-like properties, along with potent anti-inflammatory and anti-apoptotic effects. It is expressed in various tissues, including tumors. <b>Methods:</b> We investigated the levels of RNLS in the blood of CML patients in the chronic phase, treatment naïve patients, and those in remission under TKI treatment (either imatinib or nilotinib) and compared them to healthy individuals. <b>Results:</b> Renalase concentration was markedly decreased in treatment-naive CML patients compared to other groups (<i>p</i> = 0.000), while lower levels in the TKI group were not statistically significant compared to controls. The levels correlated negatively with the total leukocyte and neutrophil count (<i>p</i> < 0.05), while a positive correlation was present with CRP levels in treatment naïve patients. <b>Conclusions:</b> Dynamic regulation of RNLS expression and activity is coupled with transcription factors NF-κB and STAT3. Interpretation of our results might rely on differential requirements of activated STATs (STAT3/5) during CML clone development and maintenance, including the observation of RNLS rise upon TKI introduction. Overall, our research provides new insights into the field of hematological malignancies. Unlike other malignancies studied, RNLS plasma levels are significantly decreased in CML. In future perspectives, RNLS could potentially serve as a diagnostic, prognostic, or therapeutic option for these patients.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"787-796"},"PeriodicalIF":2.7,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11676128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Kidney Disease of Unknown Etiology: A Global Health Threat in Rural Agricultural Communities-Prevalence, Suspected Causes, Mechanisms, and Prevention Strategies. 病因不明的慢性肾病:农村农业社区的全球健康威胁——患病率、疑似病因、机制和预防策略。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-12-09 DOI: 10.3390/pathophysiology31040052
Zineb Ben Khadda, Haitam Lahmamsi, Yahya El Karmoudi, Said Ezrari, Laila El Hanafi, Tarik Sqalli Houssaini

Chronic Kidney Disease of Unknown Etiology (CKDu) is a worldwide hidden health threat that is associated with progressive loss of kidney functions without showing any initial symptoms until reaching end-stage renal failure, eventually leading to death. It is a growing health problem in Asia, Central America, Africa, and the Middle East, with identified hotspots. CKDu disease mainly affects young men in rural farming communities, while its etiology is not related to hypertension, kidney stones, diabetes, or other known causes. The main suspected causal factors are heat-stress, dehydration, exposure to agrochemicals, heavy metals and use of hard water, infections, mycotoxins, nephrotoxic agents, altitude, and genetic factors. This review gives an overview of CKDu and sheds light on its medical history, geographic distribution, and worldwide prevalence. It also summarizes the suspected causal factors, their proposed mechanisms of action, as well as the main methods used in the CKDu prior detection and surveillance. In addition, mitigation measures to reduce the burden of CKDu are also discussed. Further investigation utilizing more robust study designs would provide a better understanding of the risk factors linked to CKDu and their comparison between affected regions.

病因不明的慢性肾脏疾病(CKDu)是一种全球性的隐性健康威胁,它与肾脏功能的进行性丧失有关,在达到终末期肾功能衰竭之前没有任何初始症状,最终导致死亡。在亚洲、中美洲、非洲和中东,这是一个日益严重的健康问题,已经确定了热点地区。CKDu主要影响农村农业社区的年轻男性,其病因与高血压、肾结石、糖尿病或其他已知病因无关。主要怀疑的致病因素有热应激、脱水、接触农用化学品、重金属和使用硬水、感染、真菌毒素、肾毒性制剂、海拔和遗传因素。本文综述了CKDu的概况,并阐明了其病史、地理分布和全球患病率。本文还总结了CKDu可能的病因、可能的作用机制,以及CKDu早期检测和监测的主要方法。此外,还讨论了减轻CKDu负担的缓解措施。采用更可靠的研究设计的进一步调查将更好地了解与CKDu相关的风险因素及其在受影响地区之间的比较。
{"title":"Chronic Kidney Disease of Unknown Etiology: A Global Health Threat in Rural Agricultural Communities-Prevalence, Suspected Causes, Mechanisms, and Prevention Strategies.","authors":"Zineb Ben Khadda, Haitam Lahmamsi, Yahya El Karmoudi, Said Ezrari, Laila El Hanafi, Tarik Sqalli Houssaini","doi":"10.3390/pathophysiology31040052","DOIUrl":"10.3390/pathophysiology31040052","url":null,"abstract":"<p><p>Chronic Kidney Disease of Unknown Etiology (CKDu) is a worldwide hidden health threat that is associated with progressive loss of kidney functions without showing any initial symptoms until reaching end-stage renal failure, eventually leading to death. It is a growing health problem in Asia, Central America, Africa, and the Middle East, with identified hotspots. CKDu disease mainly affects young men in rural farming communities, while its etiology is not related to hypertension, kidney stones, diabetes, or other known causes. The main suspected causal factors are heat-stress, dehydration, exposure to agrochemicals, heavy metals and use of hard water, infections, mycotoxins, nephrotoxic agents, altitude, and genetic factors. This review gives an overview of CKDu and sheds light on its medical history, geographic distribution, and worldwide prevalence. It also summarizes the suspected causal factors, their proposed mechanisms of action, as well as the main methods used in the CKDu prior detection and surveillance. In addition, mitigation measures to reduce the burden of CKDu are also discussed. Further investigation utilizing more robust study designs would provide a better understanding of the risk factors linked to CKDu and their comparison between affected regions.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"761-786"},"PeriodicalIF":2.7,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11677577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rat Models in Post-Traumatic Stress Disorder Research: Strengths, Limitations, and Implications for Translational Studies. 创伤后应激障碍研究中的大鼠模型:优势、局限性和对转化研究的启示。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-12-06 DOI: 10.3390/pathophysiology31040051
Alexey Sarapultsev, Maria Komelkova, Oleg Lookin, Sergey Khatsko, Evgenii Gusev, Alexander Trofimov, Tursonjan Tokay, Desheng Hu

Post-Traumatic Stress Disorder (PTSD) is a multifaceted psychiatric disorder triggered by traumatic events, leading to prolonged psychological distress and varied symptoms. Rat models have been extensively used to explore the biological, behavioral, and neurochemical underpinnings of PTSD. This review critically examines the strengths and limitations of commonly used rat models, such as single prolonged stress (SPS), stress-re-stress (S-R), and predator-based paradigms, in replicating human PTSD pathology. While these models provide valuable insights into neuroendocrine responses, genetic predispositions, and potential therapeutic targets, they face challenges in capturing the full complexity of PTSD, particularly in terms of ethological relevance and translational validity. We assess the degree to which these models mimic the neurobiological and behavioral aspects of human PTSD, highlighting areas where they succeed and where they fall short. This review also discusses future directions in refining these models to improve their utility for translational research, aiming to bridge the gap between preclinical findings and clinical applications.

创伤后应激障碍(PTSD)是一种由创伤性事件引发的多方面精神障碍,可导致长期的心理困扰和多种症状。大鼠模型已被广泛用于探索创伤后应激障碍的生物学、行为学和神经化学基础。本文综述了常用的大鼠模型的优势和局限性,如单次延长应激(SPS)、应激-再应激(S-R)和基于捕食者的范式,在复制人类创伤后应激障碍病理方面。虽然这些模型为神经内分泌反应、遗传易感性和潜在的治疗靶点提供了有价值的见解,但它们在捕捉创伤后应激障碍的全部复杂性方面面临挑战,特别是在行为学相关性和转化有效性方面。我们评估了这些模型模拟人类创伤后应激障碍的神经生物学和行为方面的程度,突出了它们成功的领域和不足的领域。本文还讨论了改进这些模型的未来方向,以提高其在转化研究中的效用,旨在弥合临床前研究结果与临床应用之间的差距。
{"title":"Rat Models in Post-Traumatic Stress Disorder Research: Strengths, Limitations, and Implications for Translational Studies.","authors":"Alexey Sarapultsev, Maria Komelkova, Oleg Lookin, Sergey Khatsko, Evgenii Gusev, Alexander Trofimov, Tursonjan Tokay, Desheng Hu","doi":"10.3390/pathophysiology31040051","DOIUrl":"10.3390/pathophysiology31040051","url":null,"abstract":"<p><p>Post-Traumatic Stress Disorder (PTSD) is a multifaceted psychiatric disorder triggered by traumatic events, leading to prolonged psychological distress and varied symptoms. Rat models have been extensively used to explore the biological, behavioral, and neurochemical underpinnings of PTSD. This review critically examines the strengths and limitations of commonly used rat models, such as single prolonged stress (SPS), stress-re-stress (S-R), and predator-based paradigms, in replicating human PTSD pathology. While these models provide valuable insights into neuroendocrine responses, genetic predispositions, and potential therapeutic targets, they face challenges in capturing the full complexity of PTSD, particularly in terms of ethological relevance and translational validity. We assess the degree to which these models mimic the neurobiological and behavioral aspects of human PTSD, highlighting areas where they succeed and where they fall short. This review also discusses future directions in refining these models to improve their utility for translational research, aiming to bridge the gap between preclinical findings and clinical applications.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"709-760"},"PeriodicalIF":2.7,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11679995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Placental Macrovascular Pattern from Pregnancies with Maternal Hypertensive and Fetal Growth Capacity Complications. 孕妇高血压和胎儿生长能力并发症的胎盘大血管模式。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-12-05 DOI: 10.3390/pathophysiology31040050
Kamilya Makhambetova, Yevgeniy Kamyshanskiy, Olga Ponamareva, Zhanna Amirbekova, Nazerke Oshakhtiyeva, Saule Kunanbaeva

Histomorphometric measurements of the wall thickness and internal diameter of the macrovessels of the chorionic villi of placentas from pregnancies complicated by preeclampsia or fetal growth restriction in comparison with normotensive pregnancy.

Methods: The research included placentas from singleton pregnancies complicated by preeclampsia and/or fetal growth restriction, women delivered in medical institutions in Karaganda city (Kazakhstan). Placentas were divided into three groups: PE (n = 59), isolated FGR (n = 24), and PE with FGR (n = 41). The control group consisted of normotensive pregnancies, compared by gestation period. Placental examination and selection of placental tissue fragments were carried out in accordance with the consensus recommendations of the Amsterdam Placental Workshop Group. The sections were stained with hematoxylin and eosin and Masson trichrome. Morphometric measurements were performed using ImageJ software version 1.52p.

Results: Our data showed that, in the PE group, there was a significant decrease in the wall thickness of the proximal and distal vessels with an increase in internal diameter compared with the control group (p < 0.01). In the PE + FGR group, there was a thickening of the wall of the proximal part of the vessels with a decrease in their lumen and a decrease in the wall thickness of the vessels with an increase in the lumen in the distal part compared with the control group (p < 0.01).

Conclusions: Two histopatterns of placental macrovessels in preeclampsia were revealed: the histophenotype of diffuse (proximal and distal) ectatic macroangiopathy with a thin vascular wall with a decrease in the thickness of the muscle layer and the histophenotype of proximal fibromuscular sclerosis with vascular obliteration/spasm and distal ectatic macroangiopathy. We believe that significant structural differences in vascular remodeling may reflect the different temporal and spatial nature of the pathological factor. Future research is needed to investigate the associations between histopatterns of placental vascular remodeling in preeclampsia and long-term perinatal/maternal outcomes.

妊娠合并子痫前期或胎儿生长受限的胎盘绒毛膜绒毛大血管壁厚和内径的组织形态学测量与正常妊娠的比较方法:研究对象为在哈萨克斯坦卡拉干达市医疗机构分娩的单胎妊娠合并子痫前期和/或胎儿生长受限的孕妇胎盘。将胎盘分为3组:PE组(n = 59)、分离FGR组(n = 24)、PE + FGR组(n = 41)。对照组为正常妊娠,按妊娠期进行比较。胎盘检查和胎盘组织碎片的选择是按照阿姆斯特丹胎盘研讨会小组的共识建议进行的。切片用苏木精、伊红和马松三色染色。使用ImageJ软件版本1.52 2p进行形态测量。结果:我们的数据显示,PE组与对照组相比,近端和远端血管壁厚明显减少,内径明显增加(p < 0.01)。PE + FGR组与对照组相比,近端血管壁增厚,管腔减小;远端血管壁增厚,管腔增大(p < 0.01)。结论:子痫前期胎盘大血管表现为两种组织模式:弥漫性(近端和远端)扩张性大血管病变,血管壁薄,肌层厚度减少;近端纤维肌肉硬化,血管闭塞/痉挛,远端扩张性大血管病变。我们认为,血管重构的显著结构差异可能反映了病理因素的不同时空性质。未来的研究需要调查子痫前期胎盘血管重构的组织模式和长期围产期/产妇结局之间的关系。
{"title":"Placental Macrovascular Pattern from Pregnancies with Maternal Hypertensive and Fetal Growth Capacity Complications.","authors":"Kamilya Makhambetova, Yevgeniy Kamyshanskiy, Olga Ponamareva, Zhanna Amirbekova, Nazerke Oshakhtiyeva, Saule Kunanbaeva","doi":"10.3390/pathophysiology31040050","DOIUrl":"10.3390/pathophysiology31040050","url":null,"abstract":"<p><p>Histomorphometric measurements of the wall thickness and internal diameter of the macrovessels of the chorionic villi of placentas from pregnancies complicated by preeclampsia or fetal growth restriction in comparison with normotensive pregnancy.</p><p><strong>Methods: </strong>The research included placentas from singleton pregnancies complicated by preeclampsia and/or fetal growth restriction, women delivered in medical institutions in Karaganda city (Kazakhstan). Placentas were divided into three groups: PE (<i>n</i> = 59), isolated FGR (<i>n</i> = 24), and PE with FGR (<i>n</i> = 41). The control group consisted of normotensive pregnancies, compared by gestation period. Placental examination and selection of placental tissue fragments were carried out in accordance with the consensus recommendations of the Amsterdam Placental Workshop Group. The sections were stained with hematoxylin and eosin and Masson trichrome. Morphometric measurements were performed using ImageJ software version 1.52p.</p><p><strong>Results: </strong>Our data showed that, in the PE group, there was a significant decrease in the wall thickness of the proximal and distal vessels with an increase in internal diameter compared with the control group (<i>p</i> < 0.01). In the PE + FGR group, there was a thickening of the wall of the proximal part of the vessels with a decrease in their lumen and a decrease in the wall thickness of the vessels with an increase in the lumen in the distal part compared with the control group (<i>p</i> < 0.01).</p><p><strong>Conclusions: </strong>Two histopatterns of placental macrovessels in preeclampsia were revealed: the histophenotype of diffuse (proximal and distal) ectatic macroangiopathy with a thin vascular wall with a decrease in the thickness of the muscle layer and the histophenotype of proximal fibromuscular sclerosis with vascular obliteration/spasm and distal ectatic macroangiopathy. We believe that significant structural differences in vascular remodeling may reflect the different temporal and spatial nature of the pathological factor. Future research is needed to investigate the associations between histopatterns of placental vascular remodeling in preeclampsia and long-term perinatal/maternal outcomes.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"699-708"},"PeriodicalIF":2.7,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11679333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploration of the Topical Nanoemulgel Bearing with Ferulic Acid and Essential Oil for Diabetic Wound Healing. 局部含阿魏酸和精油纳米乳用于糖尿病创面愈合的研究。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-11-25 DOI: 10.3390/pathophysiology31040049
Urati Anuradha, Valamla Bhavana, Padakanti Sandeep Chary, Nitin Pal Kalia, Neelesh Kumar Mehra

Aim: To investigate the anti-inflammatory, antioxidant, and diabetic wound healing properties of the novel topical formulation [Ferulic acid-loaded nanoemulgel (DLMGO-G)]. Methods: Ferulic acid nanoemulsion developed with lemongrass oil is investigated in diabetic wound healing. Further nanoemulsion is incorporated into 1% carbopol® 934 to obtain the DLMGO-G. Nanoemulsion was characterized for particle size, and polydispersity index (PDI) was obtained by Malvern Zetasizer (Zetasizer Nano ZS, Malvern, AL, USA), and morphology by TEM (JEM 1400, JOEL, Akishima, Japan). Furthermore, in vitro cell line and in vivo studies were carried out. Results: The developed nanoemulsion showed a globule size of 28.04 ± 0.23 nm and PDI of 0.07 ± 0.01. The morphology of nanoformulations by TEM confirmed the spherical and uniform nature. Further, the nanoformulation in in vitro cell line experiments revealed that the IC50 value was increased by 1.52 times compared to the drug solution. The treatment groups have shown that fibroblast morphologies were spindle-shaped, suggesting that nanoformulation was compatible with the cells and developed normally on nanoformulation. It also reduced ROS with improved internalization more than the control group. The in vitro wound healing model also revealed that nanoformulation had better wound healing activity. In the in vivo diabetic wound studies on male SD rats, the levels of inflammatory markers such as TNF-α, IL-6, IL-22, and IL-1β declined significantly when treated with DLMGO-G. IL-10 levels significantly increased compared to the diseased group, and MMP-9 levels were remarkably decreased compared to the diseased group. Furthermore, histopathological studies showed the regeneration and granulation of tissues. Conclusions: Thus, these findings indicate that FA-loaded nanoemulgel greatly accelerates the healing of wounds in diabetic rats.

目的:研究新型外用制剂[阿魏酸负载纳米凝胶(DLMGO-G)]的抗炎、抗氧化和糖尿病伤口愈合性能。方法:采用香茅油制备阿魏酸纳米乳,研究其在糖尿病创面愈合中的作用。进一步将纳米乳掺入1% carbopol®934中,得到DLMGO-G。采用Malvern Zetasizer (Zetasizer Nano ZS, Malvern, AL, USA)和TEM (JEM 1400, JOEL, Akishima, Japan)分别对纳米乳液的粒径和形貌进行了表征。此外,还进行了体外细胞系和体内研究。结果:制备的纳米乳粒径为28.04±0.23 nm, PDI为0.07±0.01。通过透射电镜观察,证实了纳米配方的球形和均匀性。体外细胞系实验表明,纳米制剂的IC50值比药物溶液提高了1.52倍。治疗组显示成纤维细胞形态呈纺锤形,表明纳米制剂与细胞兼容,并在纳米制剂下正常发育。与对照组相比,它还减少了ROS,并改善了内化。体外创面愈合模型也显示纳米制剂具有更好的创面愈合活性。在雄性SD大鼠的体内糖尿病创面研究中,经DLMGO-G处理后,炎症标志物TNF-α、IL-6、IL-22、IL-1β水平明显下降。IL-10水平较病变组显著升高,MMP-9水平较病变组显著降低。此外,组织病理学研究显示组织再生和肉芽化。结论:负载fa纳米凝胶可显著促进糖尿病大鼠创面愈合。
{"title":"Exploration of the Topical Nanoemulgel Bearing with Ferulic Acid and Essential Oil for Diabetic Wound Healing.","authors":"Urati Anuradha, Valamla Bhavana, Padakanti Sandeep Chary, Nitin Pal Kalia, Neelesh Kumar Mehra","doi":"10.3390/pathophysiology31040049","DOIUrl":"10.3390/pathophysiology31040049","url":null,"abstract":"<p><p><b>Aim:</b> To investigate the anti-inflammatory, antioxidant, and diabetic wound healing properties of the novel topical formulation [Ferulic acid-loaded nanoemulgel (DLMGO-G)]. <b>Methods:</b> Ferulic acid nanoemulsion developed with lemongrass oil is investigated in diabetic wound healing. Further nanoemulsion is incorporated into 1% carbopol<sup>®</sup> 934 to obtain the DLMGO-G. Nanoemulsion was characterized for particle size, and polydispersity index (PDI) was obtained by Malvern Zetasizer (Zetasizer Nano ZS, Malvern, AL, USA), and morphology by TEM (JEM 1400, JOEL, Akishima, Japan). Furthermore, in vitro cell line and in vivo studies were carried out. <b>Results:</b> The developed nanoemulsion showed a globule size of 28.04 ± 0.23 nm and PDI of 0.07 ± 0.01. The morphology of nanoformulations by TEM confirmed the spherical and uniform nature. Further, the nanoformulation in in vitro cell line experiments revealed that the IC50 value was increased by 1.52 times compared to the drug solution. The treatment groups have shown that fibroblast morphologies were spindle-shaped, suggesting that nanoformulation was compatible with the cells and developed normally on nanoformulation. It also reduced ROS with improved internalization more than the control group. The in vitro wound healing model also revealed that nanoformulation had better wound healing activity. In the in vivo diabetic wound studies on male SD rats, the levels of inflammatory markers such as TNF-α, IL-6, IL-22, and IL-1β declined significantly when treated with DLMGO-G. IL-10 levels significantly increased compared to the diseased group, and MMP-9 levels were remarkably decreased compared to the diseased group. Furthermore, histopathological studies showed the regeneration and granulation of tissues. <b>Conclusions:</b> Thus, these findings indicate that FA-loaded nanoemulgel greatly accelerates the healing of wounds in diabetic rats.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"680-698"},"PeriodicalIF":2.7,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11678672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interplay Between Vitamin D Levels and Heavy Metals Exposure in Pregnancy and Childbirth: A Systematic Review. 孕期和分娩时维生素 D 水平与重金属暴露之间的相互作用:系统回顾。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-11-21 DOI: 10.3390/pathophysiology31040048
Tania Flores-Bazán, Jeannett Alejandra Izquierdo-Vega, José Antonio Guerrero-Solano, Araceli Castañeda-Ovando, Diego Estrada-Luna, Angélica Saraí Jiménez-Osorio

Background/objectives: Vitamin D (VD) deficiency has been associated with increased risk of gestational disorders affecting the endocrine system, immune system, and neurodevelopment in offspring. Recent studies have focused on the interaction between toxic elements and micronutrients during pregnancy. This review analyzes the potential relationships between VD levels and heavy metals in pregnant women and their offspring.

Methods: A systematic review was conducted according to PRISMA 2020 guidelines, using databases such as PubMed, ScienceDirect, Cochrane Library, and Google Scholar. Boolean operators 'AND' and 'OR' were applied with terms like 'pregnancy', 'vitamin D', 'heavy metals', and 'newborns'.

Results: From 4688 articles, 14 studies were selected based on relevance and quality. These studies measured the levels of metals like lead (Pb), cadmium (Cd), mercury (Hg), and arsenic (As), in biological samples including maternal blood, umbilical cord blood, placenta tissue, and meconium during different stages of pregnancy, showing an inverse relationship between VD deficiency and heavy metal concentrations, which could be related to the incidence of preterm birth.

Conclusions: The review highlights the importance of maintaining adequate VD levels during pregnancy, suggesting that sufficient VD may mitigate the adverse effects of heavy metal exposure, potentially reducing pregnancy-related complications.

背景/目的:维生素 D(VD)缺乏与影响内分泌系统、免疫系统和后代神经发育的妊娠疾病风险增加有关。最近的研究主要集中在孕期有毒元素与微量营养素之间的相互作用。本综述分析了孕妇及其后代体内 VD 水平与重金属之间的潜在关系:根据 PRISMA 2020 指南,利用 PubMed、ScienceDirect、Cochrane Library 和 Google Scholar 等数据库进行了系统综述。对 "妊娠"、"维生素 D"、"重金属 "和 "新生儿 "等术语使用布尔运算符 "AND "和 "OR":从 4688 篇文章中,根据相关性和质量筛选出 14 项研究。这些研究测量了妊娠不同阶段母体血液、脐带血、胎盘组织和胎粪等生物样本中的铅 (Pb)、镉 (Cd)、汞 (Hg) 和砷 (As) 等金属的含量,结果表明维生素 D 缺乏与重金属浓度之间存在反比关系,这可能与早产的发生率有关:本综述强调了在孕期保持足够VD水平的重要性,表明充足的VD可减轻重金属暴露的不良影响,从而可能减少与妊娠相关的并发症。
{"title":"Interplay Between Vitamin D Levels and Heavy Metals Exposure in Pregnancy and Childbirth: A Systematic Review.","authors":"Tania Flores-Bazán, Jeannett Alejandra Izquierdo-Vega, José Antonio Guerrero-Solano, Araceli Castañeda-Ovando, Diego Estrada-Luna, Angélica Saraí Jiménez-Osorio","doi":"10.3390/pathophysiology31040048","DOIUrl":"10.3390/pathophysiology31040048","url":null,"abstract":"<p><strong>Background/objectives: </strong>Vitamin D (VD) deficiency has been associated with increased risk of gestational disorders affecting the endocrine system, immune system, and neurodevelopment in offspring. Recent studies have focused on the interaction between toxic elements and micronutrients during pregnancy. This review analyzes the potential relationships between VD levels and heavy metals in pregnant women and their offspring.</p><p><strong>Methods: </strong>A systematic review was conducted according to PRISMA 2020 guidelines, using databases such as PubMed, ScienceDirect, Cochrane Library, and Google Scholar. Boolean operators 'AND' and 'OR' were applied with terms like 'pregnancy', 'vitamin D', 'heavy metals', and 'newborns'.</p><p><strong>Results: </strong>From 4688 articles, 14 studies were selected based on relevance and quality. These studies measured the levels of metals like lead (Pb), cadmium (Cd), mercury (Hg), and arsenic (As), in biological samples including maternal blood, umbilical cord blood, placenta tissue, and meconium during different stages of pregnancy, showing an inverse relationship between VD deficiency and heavy metal concentrations, which could be related to the incidence of preterm birth.</p><p><strong>Conclusions: </strong>The review highlights the importance of maintaining adequate VD levels during pregnancy, suggesting that sufficient VD may mitigate the adverse effects of heavy metal exposure, potentially reducing pregnancy-related complications.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"660-679"},"PeriodicalIF":2.7,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pathophysiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1